This site is intended for healthcare professionals

Immuno-oncotherapy News 1/2021 Slovak edition

Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma

Immuno-oncotherapy News 1/2021 Slovak edition

Background Lenvatinib in combination with pembrolizumab or everolimus has activity against advanced renal cell carcinoma. The efficacy of these regimens as compared with that of sunitinib is unclear.   Methods In this phase 3 trial, we randomly assigned (in a 1:1:1 ratio) patients with advanced renal cell carcinoma and no previous systemic therapy to receive...

Zpět

Česká diabetologie 1/2025

01 | 04 | 2025

Pripravujeme prvé tohtoročné číslo časopisu Česká diabetologie.

Onemocnění hltanu a jícnu

28 | 03 | 2025

Práve vyšiel piaty zväzok reedície Albertovej zbierky.

Study Report - Shrnutí a komentář randomizované studie MAJIC-PV

19 | 12 | 2024

Už čoskoro vyjde nové číslo Study Report, ktoré prináša správu o štúdii MAJIC-PV.




Partneři projektu